Core 3: Bioinformatics and Biostatistics Core

总结 埃默里肺癌P01应用程序旨在破译免疫治疗的潜在机制 LKB 1-mut肺癌的耐药性，并通过三个相互关联的项目寻求可能的治疗方案 来解决这一迫切的未满足的医疗需求。生物信息学和生物统计学核心（Core） 3)提供强大而透明的分析策略，复杂而综合的数据分析， 管理平台和最先进的方法，以最大限度地提高整个计划的成功 通过引导和促进数据驱动的互动和协作。为了实现这一目标，我们的Core 3团队 的研究者在生物统计学、生物信息学和 医学信息学和数据管理对于严格的实验设计和简化数据至关重要 分析、解释、共享和管理基本机制驱动的检查和临床研究。 具体而言，我们会（i）提供全面的生物统计专业知识和资源，以支援肺癌 P01项目，包括新的临床试验设计;（ii）提供一个新的综合计算平台， 阐明GDH 1（项目1）、IAP/STING（项目2）和FAK（项目3）的分子基础- 与项目负责人一起研究LKB 1缺陷型肺癌的依赖性肿瘤发生;以及（iii）开发和维持 集中式数据采集和管理系统，专门为该P01定制。核心3作为 P01的协调中心，以确保数据的完整性，科学严谨性和共享;并促进 基于机械和临床结果的综合分析以及与每个项目的密切互动的项目 核心1和核心2通过共享数据库。作为P01计划的重要组成部分，核心 3对于进一步保障和提升本P01的整个研究质量以支持开发至关重要 下一代有效的抗癌免疫为基础的治疗策略与LKB患者1 变异的肺癌

SUMMARY The Emory Lung Cancer P01 application aims to decipher the underlying mechanisms of immunotherapy resistance of LKB1-mut lung cancer and to seek possible therapeutic solutions with three interconnected projects to address this urgent unmet medical need. The function of the Bioinformatics and Biostatistics Core (Core 3) is to provide robust and transparent analytic strategies, sophisticated and integrated data analysis and management platforms, and state-of-the-art methodologies to maximize the success of the overall program through guiding and fostering data-driven interactions and collaborations. To support this goal, our Core 3 team of investigators has complementary expertise and extensive experience in biostatistics, bioinformatics, and medical informatics and data management that is critical for rigorous experimental design and streamlined data analysis, interpretation, sharing and management for basic mechanism-driven examination and clinical studies. Specifically, we will (i) provide comprehensive biostatistical expertise and resources in support to Lung Cancer P01 projects, including novel clinical trial design; (ii) provide a new integrative computational platform to support the elucidation of the molecular basis for GDH1 (Project 1), IAP/STING (Project 2), and FAK (Project 3)- dependent tumorigenesis in LKB1-deficient lung cancer with project leaders; and (iii) develop and maintain a centralized data acquisition and management system that is customized explicitly for this P01. Core 3 serves as a focal point of the P01 to ensure data integrity, scientific rigor, and sharing; and to foster collaborations between projects based on integrated analysis of mechanistic and clinical results and close interactions with each project and Core 1 and Core 2 through a shared database. Serving as a critical component of the P01 Program, Core 3 will be critical to further safeguard and elevate the entire research quality in this P01 to support the development of the next generation of effective anticancer immunity-based therapeutic strategies for patients with LKB1 mutated lung cancer.